| dc.contributor.advisor | Juniantito, Vetnizah | |
| dc.contributor.advisor | Supratikno | |
| dc.contributor.author | Trivanjodi, Gazel Rahmad | |
| dc.date.accessioned | 2025-07-17T06:11:01Z | |
| dc.date.available | 2025-07-17T06:11:01Z | |
| dc.date.issued | 2025 | |
| dc.identifier.uri | http://repository.ipb.ac.id/handle/123456789/165179 | |
| dc.description.abstract | Busulfan merupakan agen alkilasi (alkilator) yang banyak digunakan dalam
protokol kemoterapi dan persiapan transplantasi sumsum tulang. Meskipun
busulfan banyak digunakan di bidang onkologi, informasi mengenai potensi
nefrotoksisitas busulfan melalui berbagai rute pemberian masih terbatas. Ginjal
merupakan organ vital dengan tingkat perfusi darah yang tinggi sehingga rentan
terhadap toksikan sistemik. Penelitian ini bertujuan mengevaluasi efek
histopatologis ginjal setelah pemberian busulfan melalui rute intraperitoneal dan
intratestikular pada mencit. Sebanyak 40 ekor mencit jantan dibagi secara acak
menjadi empat kelompok: kontrol, intraperitoneal (IP), intratestikular bilateral
(ITB) dan intratestikular unilateral (ITU). Sampel ginjal dikoleksi dan diamati
secara histopatologis menggunakan pewarnaan Hematoksilin-Eosin (HE). Hasil
penelitian menunjukkan adanya nekrosis epitel tubulus pada seluruh kelompok
perlakuan. Nekrosis paling parah ditemukan pada kelompok ITU, ditandai dengan
degenerasi sel tubular, piknosis nukleus, dan pelepasan debris seluler ke lumen
tubulus. Kelompok ITB menunjukkan nekrosis ringan hingga sedang, sedangkan
kelompok IP memperlihatkan perubahan yang lebih terbatas. Jumlah glomerulus
mengalami penurunan yang tidak signifikan antar kelompok perlakuan. Endapan
protein pada ruang Bowman ditemukan sporadis namun tidak meningkat signifikan.
Hasil ini menunjukkan bahwa rute pemberian busulfan secara ITU, menyebabkan
kerusakan ginjal yang lebih parah dibandingkan rute lainnya. Temuan ini
memberikan informasi penting dalam pemilihan rute pemberian busulfan pada studi
eksperimental dan aplikasi biomedis. | |
| dc.description.abstract | Busulfan is an alkylating agent (alkylator) that is widely used in
chemotherapy protocols and bone marrow transplant preparation. Although
busulfan is widely used in oncology, information regarding the potential
nephrotoxicity of busulfan through various routes of administration is limited. The
kidney is a vital organ with a high level of blood perfusion, making it vulnerable to
systemic toxicants. This study aims to evaluate the histopathological effects of the
kidney after busulfan administration via the intraperitoneal and intratesticular
routes in mice. A total of 40 male mice were randomly divided into four groups:
control, intraperitoneal (IP), bilateral intratesticular (ITB) and unilateral
intratesticular
(ITU). Kidney samples were collected and observed
histopathologically using Hematoxylin-Eosin (HE) staining. The results showed the
presence of tubular epithelial necrosis in all treatment groups. The most severe
necrosis was found in the ITU group, characterized by tubular cell degeneration,
pycnosis of the nucleus, and release of cellular debris into the tubule lumen. The
ITB group showed mild to moderate necrosis, while the IP group showed more
limited changes. The number of glomeruli decreased insignificantly between
treatment groups. Protein deposits in Bowman's space were found sporadically but
did not increase significantly. These results suggest that the ITU route of busulfan
administration caused more severe renal damage than the other routes. These
findings provide important information in the selection of busulfan administration
route in experimental studies and biomedical applications. | |
| dc.description.sponsorship | | |
| dc.language.iso | id | |
| dc.publisher | IPB University | id |
| dc.title | Efek Pemberian Busulfan dengan Rute Berbeda Terhadap Histopatologi Ginjal pada Mencit (Mus musculus) | id |
| dc.title.alternative | The effect of giving busulfan with different routes on the histopathology of renal in mice (Mus musculus) | |
| dc.type | Skripsi | |
| dc.subject.keyword | intraperitoneal | id |
| dc.subject.keyword | intratestikular | id |
| dc.subject.keyword | kemoterapi | id |
| dc.subject.keyword | nefrotoksik | id |
| dc.subject.keyword | nekrosis | id |